<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04929743</url>
  </required_header>
  <id_info>
    <org_study_id>BTI_02_EC/20/4.5</org_study_id>
    <nct_id>NCT04929743</nct_id>
  </id_info>
  <brief_title>Randomized Clinical Trial to Evaluate the Predictability of 4.5 mm Dental Implants</brief_title>
  <official_title>Randomized Clinical Trial to Evaluate the Predictability and Evolution of Extra-short 4.5 mm Dental Implants Splinted in Partial or Complete Prostheses</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fundación Eduardo Anitua</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fundación Eduardo Anitua</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main aim of this clinical trial is to analyze the survival rate of short-length implants&#xD;
      (&lt;4.5 mm) in partial edentulism subjects. 6.5 mm length implants will be used as control arm.&#xD;
      Additionally, others clinical parameters (marginal bone loss and prosthetic associated&#xD;
      complications) will be measured.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 11, 2021</start_date>
  <completion_date type="Anticipated">January 31, 2024</completion_date>
  <primary_completion_date type="Anticipated">January 1, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Survival of implants</measure>
    <time_frame>1 year</time_frame>
    <description>Survival of implants at one year post-implantation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Marginal bone loss</measure>
    <time_frame>1 year</time_frame>
    <description>Marginal bone loss at one year post-implantation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of bleeding on probing</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of prosthetic or implant complications</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Probing pocket depth</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Partial-edentulism</condition>
  <arm_group>
    <arm_group_label>4.5 implants</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>6.5 implants</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>BTI Implant</intervention_name>
    <description>Placement of dental implants of 4.5 vs 6.5 mm length</description>
    <arm_group_label>4.5 implants</arm_group_label>
    <arm_group_label>6.5 implants</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age ≥ 18 years&#xD;
&#xD;
          -  Clinical indication to place a prosthetic bridge supported by a maximum of 4 implants&#xD;
             in the posterior sectors&#xD;
&#xD;
          -  Bone height in the area of interest sufficient to place implants 6.5mm length dental&#xD;
             implants&#xD;
&#xD;
          -  Availability to be observed during the follow-up period&#xD;
&#xD;
          -  Signature of the informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Need to perform bone augmentation surgery prior to implant placement surgery&#xD;
&#xD;
          -  Smokers (&gt; 10 cigarettes per day)&#xD;
&#xD;
          -  Patients with poorly controlled diabetes&#xD;
&#xD;
          -  Patients on chronic treatment with non-steroidal anti-inflammatory drugs&#xD;
&#xD;
          -  Patients receiving oral or intravenous bisphosphonates&#xD;
&#xD;
          -  Patients under chemotherapy or radiotherapy treatment&#xD;
&#xD;
          -  Patients receiving systemic corticosteroids&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Mikel Allende, PhD</last_name>
    <phone>+34945160653</phone>
    <phone_ext>257</phone_ext>
    <email>mikel.allende@bti-implant.es</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Mikel Allende</last_name>
    <phone>+34945160653</phone>
    <phone_ext>257</phone_ext>
    <email>mikel.allende@bti-implant.es</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Clinica Eduardo Anitua</name>
      <address>
        <city>Vitoria</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mikel Allende</last_name>
      <phone>+34945160653</phone>
      <email>mikel.allende@bti-implant.es</email>
    </contact>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>June 9, 2021</study_first_submitted>
  <study_first_submitted_qc>June 15, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 18, 2021</study_first_posted>
  <last_update_submitted>June 15, 2021</last_update_submitted>
  <last_update_submitted_qc>June 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 18, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

